Clinical Research Directory
Browse clinical research sites, groups, and studies.
35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Inflammation of Skin
Sponsor: Nakhia Impex LLC
Summary
To explore the clinical effect and safety of 35 kDa hyaluronic acid fragment ( HA35 ) combined with negative pressure microneedle technology in improving skin problems.
Official title: 35 kDa Hyaluronan Fragment (HA35) Reduces Chronic Skin Inflammation
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-04-15
Completion Date
2024-05
Last Updated
2024-05-21
Healthy Volunteers
Yes
Conditions
Interventions
35 kDa hyaluronan fragment HA35 injection
First, apply an appropriate amount of compound lidocaine cream to the treatment site ( national drug approval number H20063466 ; Beijing Ziguang Pharmaceutical Co., Ltd. ) waited for 60 minutes after applying hemp, and then injected the syringe containing sterile HA35 prepared in advance into the subcutaneous 1.0-1.5mm through the DermaShine PRO negative pressure microneedle importer ( Demasha, South Korea ).
Locations (1)
Nahia Impex LLC
Ulaanbaatar, Mongolia